The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development
Abstract
Anticancer agents that interfere with microtubulin function are in widespread use in man and have a broad spectrum of activity against both hematological malignancies and solid tumors. The mechanisms of actions of these agents have been better defined during the past decade, indicating that there are distinct binding sites for these agents and that they interfere with microtubulin dynamics (growth and shortening of tubules) at low concentrations and only evoke microtubulin aggregation or dissociation at high concentrations. Tubulin has been recently described in the nucleus of cells and in mitochondria. Downstream events from tubulin binding are believed to be critical events for the generation of apoptosis in the malignant cell. The effects of vinca alkaloids and taxanes are distinct, suggesting that the interference with the tubulin cap by high-affinity binding of effective agents is not the only mechanism of cytotoxic effect, and the low-affinity binding of drug, which distorts microtubulin function, may also be important. The epothilones share some of the binding characteristics of the taxanes and are in clinical trials because of cytoxic activity in taxane resistant cells. Tubulin has additional target sites for anticancer drugs including interference with the binding and function of microtubule associated proteins and interference with motor proteins which are essential for the transport of substances within the cell. Because many of these microtubule associated proteins have an ATP binding site, both computer-aided design and combinatorial chemistry techniques can be used to make agents to interfere with their function analogous to imatinib mesylate (Gleevec). Agents that interfere with the motor protein kinesin are entering clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dynamic instability of microtubule growth
Mitchison, T., & Kirschner, M. (1984) · Nature · doi:10.1038/312237a0 · Cited by 3,337
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Walker, R. A., O'Brien, E. T., Pryer, N. K., Soboeiro, M. F., Voter, W. A., Erickson, H. P., & Salmon, E. D. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.4.1437 · Cited by 980
Structural Insights into Microtubule Function
Nogales, E. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.277 · Cited by 782
Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., & Wilson, L. (1996) · PubMed · Cited by 770
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S., & Matthias, P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg115 · Cited by 740 · cited 1×
“microtubule associated protein, which deacetylates a-tubulin, but the biological significance of this event remains unclear.([22]) Microtubules have been associated with mitochondria accounting for 2% of total cellular tubulin.”
BackgroundPaclitaxel-induced cell death: Where the cell cycle and apoptosis come together
Wang, T.-H., Wang, H.-S., & Soong, Y.-K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2619::aid-cncr26>3.0.co;2-j · Cited by 647
Multiple Forms of Tubulin: Different Gene Products and Covalent Modifications
Ludueña, R. F. (1997) · International Review of Cytology · doi:10.1016/s0074-7696(08)62138-5 · Cited by 611
Kavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L., Norris, M. D., Haber, M., & Horwitz, S. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119642 · Cited by 601
Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells
Yvon, A.-M. C., Wadsworth, P., & Jordan, M. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.947 · Cited by 553
The spindle: a dynamic assembly of microtubules and motors
Wittmann, T., Hyman, A., & Desai, A. (2001) · Nature Cell Biology · doi:10.1038/35050669 · Cited by 515
Giannakakou, P., Gussio, R., Nogales, E., Downing, K. H., Zaharevitz, D., Bollbuck, B., Poy, G., Sackett, D., Nicolaou, K. C., & Fojo, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040546297 · Cited by 477
The Mitotic Spindle: A Self-Made Machine
Karsenti, E., & Vernos, I. (2001) · Science · doi:10.1126/science.1063488 · Cited by 456
Lee, F. Y., Borzilleri, R. M., Fairchild, C. R., Kim, S., Long, B. H., Raventós-Suárez, C., Vite, G. D., Rose, W. C., & Kramer, R. A. (2001) · PubMed · Cited by 453
Taxol: Mechanisms of Action and Resistancea
HORWITZ, S. B., LOTHSTEIN, L., MANFREDI, J. J., MELLADO, W., PARNESS, J., ROY, S. N., SCHIFF, P. B., SORBARA, L., & ZEHEB, R. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb38455.x · Cited by 416
The molecular basis and potential role of survivin in cancer diagnosis and therapy
Altieri, D. C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02243-2 · Cited by 412
Microtubules and signal transduction
Gundersen, G. G., & Cook, T. A. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80010-6 · Cited by 407
Dowlati, A., Robertson, K., Cooney, M. M., Petros, W. P., Stratford, M. R. L., Jesberger, J. A., Rafie, N., Overmoyer, B. A., Makkar, V., Stambler, B. S., et al. (2002) · PubMed · Cited by 403
Zheng, Y., Jung, M. K., & Oakley, B. R. (1991) · Cell · doi:10.1016/0092-8674(91)90389-g · Cited by 398
Taxol: the first of the taxanes, an important new class of antitumor agents.
Rowinsky, E. K., Onetto-Pothier, N., Canetta, R. M., & Arbuck, S. G. (1992) · PubMed · Cited by 389
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
Blagosklonny, M. V., Giannakakou, P., El‐Deiry, W. S., Kingston, D. G. I., Higgs, P. I., Neckers, L. M., & Fojo, T. (1997) · PubMed · Cited by 382
The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review
Wang, L. G., Liu, X. M., Kreis, W., & Budman, D. R. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050989 · Cited by 373
Self-citationp53 is associated with cellular microtubules and is transported to the nucleus by dynein
Giannakakou, P., Sackett, D. L., Ward, Y., Webster, K. R., Blagosklonny, M. V., & Fojo, T. (2000) · Nature Cell Biology · doi:10.1038/35036335 · Cited by 373
Posttranslational modification and microtubule stability.
Schulze, E., Asai, D. J., Bulinski, J. C., & Kirschner, M. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.5.2167 · Cited by 372
Molecular effects of paclitaxel: Myths and reality (a critical review)
Blagosklonny, M. V., & Fojo, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991008)83:2<151::aid-ijc1>3.0.co;2-5 · Cited by 363
The binding conformation of Taxol in β-tubulin: A model based on electron crystallographic density
Snyder, J. P., Nettles, J. H., Cornett, B., Downing, K. H., & Nogales, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051309398 · Cited by 362
Repeat motifs of tau bind to the insides of microtubules in the absence of taxol
Kar, S., Fan, J., Smith, M. J., Goedert, M., & Amos, L. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg001 · Cited by 355
Bissery, M.-C., Nohynek, G., Sanderink, G.-J., & Lavelie, F. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199506000-00001 · Cited by 323
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
Rowinsky, E. K., & Donehower, R. C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90086-2 · Cited by 321
Gundersen, G. G., Khawaja, S., & Bulinski, J. C. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.1.251 · Cited by 304
Taxanes: A New Class of Antitumor Agents
Huizing, M. T., Misser, V. H. S., Pieters, R. C., ten Bokkel Huinink, W. W., Veenhof, C. H. N., Vermorken, J. B., Pinedo, H. M., & Beijnen, J. H. (1995) · Cancer Investigation · doi:10.3109/07357909509031919 · Cited by 285
Carreá, M., Andreá, N., Carles, G., Borghi, H., Brichese, L., Briand, C., & Braguer, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203834200 · Cited by 273
Tubulin and microtubule structure
Downing, K. H., & Nogales, E. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80082-3 · Cited by 267
Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics
Gonçalves, A., Braguer, D., Kamath, K., Martello, L., Briand, C., Horwitz, S., Wilson, L., & Jordan, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191388598 · Cited by 260
Regulation of microtubule stability and mitotic progression by survivin.
Giodini, A., Kallio, M. J., Wall, N. R., Gorbsky, G. J., Tognin, S., Marchisio, P. C., Symons, M. H., & Altieri, D. C. (2002) · PubMed · Cited by 256
Microtubule Dynamic Instability and GTP Hydrolysis
Erickson, H. P., & O'Brien, E. T. (1992) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.bb.21.060192.001045 · Cited by 247
Past and future of the mitotic spindle as an oncology target
Wood, K. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00064-9 · Cited by 244
Giannakakou, P., Robey, R., Fojo, T., & Blagosklonny, M. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204487 · Cited by 229
Müller-Reichert, T., Chrétien, D., Severin, F., & Hyman, A. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3661 · Cited by 223
Kavallaris, M., Tait, A., Walsh, B. J., He, L., Horwitz, S. B., Norris, M. D., & Haber, M. (2001) · PubMed · Cited by 221
Wang, T.-H., Popp, D. M., Wang, H.-S., Saitoh, M., Mural, J. G., Henley, D. C., Ichijo, H., & Wimalasena, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8208 · Cited by 216
Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
Chen, J.-G., & Horwitz, S. B. (2002) · PubMed · Cited by 212
Lobert, S., Vulevic, B., & Correia, J. J. (1996) · Biochemistry · doi:10.1021/bi953037i · Cited by 212
Giannakakou, P., Nakano, M., Nicolaou, K. C., O'Brate, A., Yu, J., Blagosklonny, M. V., Greber, U. F., & Fojo, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132275599 · Cited by 205
Kinesin molecular motors: Transport pathways, receptors, and human disease
Goldstein, L. S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111145298 · Cited by 201
G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells
Blajeski, A. L., Phan, V. A., Kottke, T. J., & Kaufmann, S. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13275 · Cited by 200
The role of β-tubulin isotypes in resistance to antimitotic drugs
Burkhart, C. A., Kavallaris, M., & Horwitz, S. B. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00022-6 · Cited by 198
Altmann, K.-H., Wartmann, M., & O’Reilly, T. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00009-3 · Cited by 191
Accessory protein regulation of microtubule dynamics throughout the cell cycle
Cassimeris, L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80017-9 · Cited by 184
Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky, M. S., Wang, E. E., Rudin, C. M., Blagosklonny, M. V., & Fojo, T. (1998) · PubMed · Cited by 183
Yoshimatsu, K., Yamaguchi, A., Yoshino, H., Koyanagi, N., & Kitoh, K. (1997) · PubMed · Cited by 181
Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
Kavallaris, M., Burkhart, C. A., & Horwitz, S. B. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690507 · Cited by 179
Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.
Blakey, D. C., Westwood, F. R., Walker, M., et al. (2002) · PubMed · Cited by 176
Localization of the Vinblastine-binding Site on β-Tubulin
Rai, S. S., & Wolff, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14707 · Cited by 165
Characterization of the Taxol Binding Site on the Microtubule
Rao, S., He, L., Chakravarty, S., Ojima, I., Orr, G. A., & Horwitz, S. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37990 · Cited by 164
Nucleotide binding and phosphorylation in microtubule assembly in vitro
Penningroth, S. M., & Kirschner, M. W. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90108-5 · Cited by 163
Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel
Chou, T.-C., Zhang, X.-G., Harris, C. R., Kuduk, S. D., Balog, A., Savin, K. A., Bertino, J. R., & Danishefsky, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15798 · Cited by 163
Vinflunine, the latest Vinca alkaloid in clinical development
Kruczynski, A., & Hill, B. T. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00183-4 · Cited by 156
Chang, P., & Stearns, T. (1999) · Nature Cell Biology · doi:10.1038/71350 · Cited by 153
Ling, Y., Jiang, J.-D., Holland, J. F., & Perez-Soler, R. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.529 · Cited by 149
Novel molecules that interact with microtubules and have functional activity similar to Taxol™
He, L., Orr, G. A., & Horwitz, S. B. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02038-4 · Cited by 143
Verhey, K. J., & Rapoport, T. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01931-4 · Cited by 141
Three expressed sequences within the human β-tubulin multigene family each define a distinct isotype
Lewis, S. A., Gilmartin, M. E., Hall, J. L., & Cowan, N. J. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90023-3 · Cited by 133
He, L., Yang, C. P., & Horwitz, S. B. (2001) · PubMed · Cited by 131
Diversity screening versus focussed screening in drug discovery
Valler, M. J., & Green, D. V. S. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01517-8 · Cited by 130
Anticancer therapy with novel tubulin-interacting drugs
Kavallaris, M., Verrills, N. M., & Hill, B. T. (2001) · Drug Resistance Updates · doi:10.1054/drup.2002.0230 · Cited by 129
Microtubule treadmilling: what goes around comes around
Margolis, R. L., & Wilson, L. (1998) · BioEssays · Cited by 121
The three-dimensional structure of tubulin protofilaments
Amos, L., & Baker, T. S. (1979) · Nature · doi:10.1038/279607a0 · Cited by 117
Lewis, S. A., & Cowan, N. J. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.6.2023 · Cited by 112
Recent Progress in the Development of Tubulin Inhibitors As Antimitotic Antitumor Agents
Lee, K., Shi, Q., Chen, K., & Morris-Natschke, S. L. (1970) · Current Pharmaceutical Design · doi:10.2174/138161280403221007124425 · Cited by 105
Wubbolts, R., Fernandez‐Borja, M., Jordens, I., Reits, E. A., Dusseljee, S., Echeverri, C. J., Vallee, R. B., & Neefjes, J. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.6.785 · Cited by 103
Microtubule alterations and resistance to tubulin-binding agents (Review)
Drukman, S., & Kavallaris, M. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.3.621 · Cited by 102
A plus-end raft to control microtubule dynamics and function
Galjart, N., & Perez, F. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00007-8 · Cited by 101
Panda, D., Miller, H. P., Islam, K., & Wilson, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10560 · Cited by 95
Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy.
Mistry, S. J., & Atweh, G. F. (2002) · PubMed · Cited by 89
Roberge, M., Cinel, B., Anderson, H. J., Lim, L., Jiang, X., Xu, L., Bigg, C. M., Kelly, M. T., & Andersen, R. J. (2000) · PubMed · Cited by 82
Inhibitors of Kinesin Activity from Structure-Based Computer Screening
Hopkins, S. C., Vale, R. D., & Kuntz, I. D. (2000) · Biochemistry · doi:10.1021/bi992474k · Cited by 81
Shionoya, M., Jimbo, T., Kitagawa, M., Soga, T., & Tohgo, A. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01465.x · Cited by 77
Dustin, P. (1980) · Scientific American · doi:10.1038/scientificamerican0880-66 · Cited by 77
Translating basic cancer research into new cancer therapeutics
Workman, P., & Kaye, S. B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02319-5 · Cited by 74
Roach, M. C., Boucher, V. L., Walss‐Bass, C., Ravdin, P. M., & Ludueña, R. F. (1998) · Cell Motility and the Cytoskeleton · Cited by 72
Stewart, Z. A., Tang, L. J., & Pietenpol, J. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204060 · Cited by 69
Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents
Altaha, R., Fojo, T., Reed, E., et al. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394043 · Cited by 69
Direct photoaffinity labeling of tubulin with colchicine.
Wolff, J., Knipling, L., CAHNMANN, H. J., & Palumbo, G. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2820 · Cited by 68
New insights into microtubule structure and function from the atomic model of tubulin
Downing, K. H., & Nogales, E. (1998) · European Biophysics Journal · doi:10.1007/s002490050153 · Cited by 67
Yamamoto, K., Noda, K., Yoshimura, A., Fukuoka, M., Furuse, K., & Niitani, H. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050795 · Cited by 64
Poruchynsky, M. S., Giannakakou, P., Ward, Y., Bulinski, J. C., Telford, W. G., Robey, R. W., & Fojo, T. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00804-8 · Cited by 59
Glass‐Marmor, L., & Beitner, R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00155-7 · Cited by 57
Mühlradt, P. F., & Sasse, F. (1997) · PubMed · Cited by 56
Panda, D., Miller, H. P., & Wilson, L. (2002) · Biochemistry · doi:10.1021/bi011767m · Cited by 49
Preclinical antitumor activity of two novel taxanes
Rose, W. C., Fairchild, C. A., & Lee, F. Y. F. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000241 · Cited by 48
Combretastatin-A4 disrupts neovascular development in non-neoplastic tissue
Griggs, J., Hesketh, R., Smith, G. A., Brindle, K. M., Metcalfe, J. C., Thomas, G. A., & Williams, E. D. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1653 · Cited by 47
Mechanisms of action and resistance to tubulin-binding agents
Dumontet, C. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.779 · Cited by 47
Derry, W. B., Wilson, L., & Jordan, M. A. (1998) · PubMed · Cited by 44
Hidalgo, M. M., Aylesworth, C. A., Hammond, L. A., Britten, C. D., Weiss, G. R., Stephenson, J., Schwartz, G. H., Patnaik, A., Smith, L. S., Molpus, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2493 · Cited by 42
Rubenstein, S. M., Baichwal, V. R., Beckmann, H., Clark, D. L., Frankmoelle, W. P., Roche, D., Santha, E., Schwender, S., Thoolen, M., Ye, Q., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000478d · Cited by 40
Calmodulin-containing substructures of the centrosomal matrix released by microtubule perturbation
Moisoi, N., Erent, M., Whyte, S. M., Martin, S. R., & Bayley, P. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.11.2367 · Cited by 30
Jenkins, S. M., & Johnson, G. V. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741463.x · Cited by 27
Farshori, P., & Goode, D. (1994) · PubMed · Cited by 22
Jordan, M. A., & Farrell, K. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90647-4 · Cited by 16
Cited by
De Martino, G., Edler, M. C., La Regina, G., Coluccia, A., Barbera, M. C., Barrow, D., Nicholson, R. I., Chiosis, G., Brancale, A., Hamel, E., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050809s · Cited by 367
Recent developments in tubulin polymerization inhibitors: An overview
Kaur, R., Kaur, G., Gill, R. K., Soni, R., & Bariwal, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.051 · Cited by 344
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Martino, E., Casamassima, G., Castiglione, S., Cellupica, E., Pantalone, S., Papagni, F., Rui, M., Siciliano, A. M., & Collina, S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.06.044 · Cited by 337
Imidazole, oxazole and thiazole alkaloids
Jin, Z. (2006) · Natural Product Reports · doi:10.1039/b502166a · Cited by 270
Metadata
- Authors
- Pellegrini, F., & Budman, D. R.
- Venue
- Cancer Investigation
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 23
- Issue
- 3
- Pages
- 264-273
- ISSN
- 0735-7907 (ISSN-L)
- 1532-4192
- OpenAlex
- W2106521963
- Cited by
- 313
- References
- 100
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.